THE ANTIHYPERTENSIVE MARKET IS EXPECTED TO EXCEED $50BN BY 2014 ACROSS THE SEVEN MAJOR MARKETS

Research and Markets has announced the addition of Antihypertensives — Two Years to Shape the Market? to their offering. The antihypertensive market is expected to exceed $50bn by 2014 across the seven major markets, with novel treatments and the market-leading ARBs delivering much of this value. However, significant hurdles exist, and pharmaceutical companies need to be savvy regarding marketing and pricing structures for their products, as only the most cunning and aggressive companies look set to survive.
Genetic Engineering News